TRACY TING

Executive Compensation (Public Companies): Extensive experience working with Compensation Committees on executive compensation strategy, short- and long-term incentive plan design, CEO compensation and performance reviews, Board compensation, proxy and other SEC disclosures, ISS and Glass Lewis considerations, risk assessments, peer benchmarking, and regulatory developments.

Financial Expert: Meets NASDAQ requirements for “financial literacy” and NYSE requirements for “financial sophistication.”

Board Committee Leadership: More than 20 years of experience inside the boardroom working with Compensation Committees, Nominating and Governance Committees, and corporate boards at public and private companies. Deep experience with Board and C-suite recruitment, as well as Board and executive succession planning.

Business Transformation & Sale of a Public Company: Key member of the Affymetrix executive team that led the successful business and culture turnaround across a footprint spanning more than 20 countries, resulting in the company’s $1.3 billion acquisition by Thermo Fisher Scientific in March 2016.

Executive/Leadership & Board Development: Deep experience with CEO and executive succession planning and advising Boards on enhancing board effectiveness.

Environmental, Social & Governance (ESG): Chair of Encore Capital Group’s global steering committee, which created the company’s ESG strategy and multi-year roadmap, including the issuance of its first ESG Report in 2022.

Expertise in Highly Regulated Industries: Experience across biotech, medical devices, pharmaceuticals, and financial services, including global companies with $1–3 billion in annual revenues and employee footprints spanning 10 to 40 countries.

Thought Leader: Frequent podcast guest, keynote speaker, and conference speaker at organizations and events including the HR Management Institute, Equilar, and Athena. Topics include business transformation, culture, talent, and innovation.